Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements
September 29 2022 - 9:00AM
Business Wire
Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a
biotech innovation company developing and commercializing
technologies with a focus on monitoring and modulating the immune
system, today announces it has received confirmation from The
Nasdaq Stock Market LLC Hearing Panel (“Nasdaq”) that it has
regained compliance with the minimum bid price requirement of $1.00
per share under Nasdaq Listing Rule 5550(a)(2), meets the
stockholders’ equity requirement in Nasdaq Listing Rule 5550(b)(1)
and meets all other applicable criteria for continued listing.
Aditxt recently completed a reverse stock split and closed a $20
million public offering. Amro Albanna, co-founder, chairman and CEO
of Aditxt, said both events were key to the Company’s successful
Nasdaq compliance and continued progress within each of the
Company’s programs toward commercialization, which currently
include AditxtScore™, Adimune™ and Adivir™.
About Aditxt, Inc.
Aditxt is a biotech innovation company developing and
commercializing technologies with a focus on monitoring and
modulating the immune system. Aditxt’s immune monitoring
technologies are designed to provide a personalized immune profile.
Aditxt’s immune modulating technologies, currently preclinical, are
being developed to retrain the immune system to induce tolerance to
address rejection of transplanted organs, autoimmune diseases and
allergies.
For more information, please visit: www.Aditxt.com and
www.AditxtScore.com
Forward-Looking Statements
Certain statements in this press release constitute
"forward-looking statements" within the meaning of federal
securities laws. Forward-looking statements include statements
regarding the Company's intentions, beliefs, projections, outlook,
analyses or current expectations concerning, among other things,
the Company's ongoing and planned product and business development;
the Company's intellectual property position; the Company's ability
to develop commercial functions; expectations regarding product
launch and revenue; the Company's results of operations, cash
needs, spending, financial condition, liquidity, prospects, growth
and strategies; the industry in which the Company operates; and the
trends that may affect the industry or the Company. Forward-looking
statements are not guarantees of future performance and actual
results may differ materially from those indicated by these
forward-looking statements as a result of various important
factors, as well as market and other conditions and those risks
more fully discussed in the section titled "Risk Factors" in the
Company's most recent Annual Report on Form 10-K, as well as
discussions of potential risks, uncertainties, and other important
factors in the Company's other filings with the Securities and
Exchange Commission. All such statements speak only as of the date
made, and the Company undertakes no obligation to update or revise
publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220929005565/en/
Media and Investor Relations Contact: ir@aditxt.com
www.aditxt.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Sep 2023 to Sep 2024